ARASENS Phase 3 Trial of ODM-201 in Men with Metastatic Hormone-Sensitive Prostate Cancer (Mhspc).Matthew Raymond Smith,Fred Saad,Maha Hussain,Cora N. Sternberg,Karim Fizazi,E. David Crawford,Karin Sayuri Yamada,Christian Kappeler,Iris Kuss,Bertrand F. TombalJournal of clinical oncology（2017）引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
